On September 7, Buchang Pharmaceutical issued an announcement stating that its wholly-owned subsidiary, Shaanxi Buchang Pharmaceutical Co.
("Shaanxi Buchang"), had recently received the "Tiangui Gengnian Soft Capsule" approved and issued by the State Drug Administration.
Notification of Approval of Drug Supplement Application
Tiangui Gengnian Soft Capsule has the functions of nourishing liver and kidney, promoting blood circulation and removing blood stasis
Used for menopausal syndrome, which is of liver and kidney yin deficiency and blood stasis syndrome, which can improve symptoms such as heat and sweat, irritability, insomnia, forgetfulness, dizziness, tinnitus, waist and knee pain, chest tightness, hypochondriac pain, dry stool, skin pruritus, etc.
According to data inquiries from Minai.
com, the annual sales trend of proprietary Chinese medicines in Chinese urban retail pharmacies in 2020 shows that the sales of Tiangui menopause soft capsules are 70,000 yuan
As of the date of this announcement, the company has invested approximately RMB 51.
16 million in Tiangui menopause soft capsules